摘要
目的 分析右美托咪定在无痛胃镜中的麻醉治疗效果。方法 研究时间选取2020年10月-2021年10月,研究对象为我院接受无痛胃镜的患者86例,按照数字表随机交替排序法分为两组各43例,即采取丙泊酚麻醉的对照组与联合右美托咪定麻醉的观察组,比较两组的麻醉效果。结果 观察组的麻醉起效时间、持续时间优于对照组(t=8.154、13.165,P<0.05),但苏醒恢复时间无差异(t=1.017,P>0.05);观察组在治疗时与治疗后的疼痛VAS评分低于对照组,镇静Ramsay评分高于对照组(t=6.716、5.424,t=5.190、7.702,P<0.05);观察组的不良反应发生率6.98%(3/43)低于对照组18.60%(8/43)(χ2=6.053,P<0.05)。结论 在无痛胃镜中应用右美托咪定的麻醉效果良好,可显著提高镇痛镇静作用,且用药安全性更高,值得推广。
关键词: 无痛胃镜;右美托咪定;麻醉效果;不良反应
Abstract
Objective: To analyze the anesthetic effect of dexmedetomidine in painless gastroscopy. Methods: From October 2020 to October 2021, 86 patients who received painless gastroscopy in our hospital were selected for the study. They were randomly divided into two groups, 43 patients in each group, according to the number table and the alternating order method. That is, the control group with propofol anesthesia and the observation group with dexmedetomidine anesthesia were used to compare the anesthetic effects of the two groups. Results: The onset time and duration of anesthesia in the observation group were better than those in the control group (t=8.154, 13.165, P<0.05), but there was no difference in recovery time (t=1.017, P>0.05); The VAS score of pain during and after treatment in the observation group was lower than that in the control group, and the Ramsay score of sedation was higher than that in the control group (t=6.716, 5.424, t=5.190, 7.702, P<0.05); The incidence of adverse reactions in the observation group was 6.98% (3/43) lower than that in the control group (18.60% (8/43))(χ2=6.053,P<0.05). Conclusion : The application of dexmedetomidine in painless gastroscope has a good anesthetic effect, can significantly improve the analgesic and sedative effects, and has higher drug safety, which is worthy of promotion.
Key words: Painless gastroscope; Dextrmedetomidine; Anesthetic effect; Adverse reactions
参考文献 References
[1] 敖程斌,黄月红,胡战兵. 右美托咪定与丙泊酚联用于老年患者无痛胃镜麻醉的临床观察[J]. 中国药师,2016, 19(2):306-307,310.
[2] 郑经旭. 胃镜检查对上消化道出血患者临床诊断及治疗的指导价值分析[J]. 影像研究与医学应用,2021, 5(23):230-231,234.
[3] 张旭东,齐玲凤,王灏,等. 丙泊酚复合右美托咪定及舒芬太尼在无痛胃镜麻醉中的临床应用研究比较[J]. 中国保健营养,2019,29(35):36.
[4] 赵静,吴仲烨,李艳. 右美托咪定喷鼻联合丙泊酚静脉注射在成人肥胖患者无痛胃镜下黏膜切除术中的麻醉效果及对苏醒质量的影响[J]. 临床医学研究与实践,2022,7(14):86-90.
[5] 王志华,王静,寇立华. 右美托咪定联合舒芬太尼在胃癌患者无痛超声胃镜检查中的应用及对患者循环系统的影响[J]. 徐州医科大学学报,2020,40(7):528-531.
[6] 张超文,刘秋安,李通城. 对比分析上消化道异物的临床治疗中应用常规胃镜和无痛胃镜的治疗效果差异[J]. 医学食疗与健康,2022,20(17):93-96.
[7] 刘忠鑫,李明,王栋. 无痛胃镜与常规胃镜在上消化道异物治疗中的临床疗效观察[J]. 现代医药卫生,2018, 34(21):3367-3369.
[8] 胡旭红. 利多卡因胶浆表面麻醉与小剂量丙泊酚联合应用对老年无痛胃镜检查患者的麻醉效果分析[J]. 现代诊断与治疗,2015,26(19):4371-4373.
[9] 王钟宇. 右美托咪定与丙泊酚联用于老年患者无痛胃镜麻醉的临床观察[J]. 中国医药指南,2017, 15(26): 41-42.
[10] 李培嫦,苟涛,张和茂,等. 右美托咪定联合丙泊酚麻醉对老年无痛胃镜检查患者生命体征的影响与安全性分析[J]. 现代医学与健康研究(电子版),2020,4(9):32-34.